NEWLY UPDATED MSCP EXAM 2026 –
MENOPAUSE SOCIETY CERTIFICATION PREP
EXAM 300 ACTUAL QUESTIONS AND CORRECT
ANSWERS WITH RATIONALE LATEST UPDATE
ALREADY GRADED A+ ASSURED PASS
The Menopause Society Certified Practitioner (MSCP) Exam 2026 is a
competency assessment for healthcare professionals specializing in midlife
women’s health. Updated for 2026, it covers physiology and pathophysiology of
menopause, symptoms and concerns, health disorders in midlife, treatment options,
and preventive care and counseling. The exam consists of 300 multiple-choice
questions with three response alternatives, testing clinical knowledge and
evidence-based practice. This comprehensive prep resource provides 300 unique
practice questions with detailed rationales, organized into five sections. It helps
candidates identify strengths, reinforce key concepts, and build confidence for
successful certification and improved overall patient care in clinical menopause
management.
SECTION 1: PHYSIOLOGY AND PATHOPHYSIOLOGY
OF THE MENOPAUSE TRANSITION (Questions 1–57)
1. What is the "climacteric phase"?
A) The final menstrual period
B) The period of endocrinologic, somatic, and transitory psychologic changes
around the time of menopause
C) The perimenopause only
D) The postmenopausal period
Answer: B) The period of endocrinologic, somatic, and transitory psychologic
changes around the time of menopause
Rationale: The climacteric phase is the broad period of endocrine, physical, and
psychological changes that occur as a woman transitions from reproductive to non-
reproductive status. It is a more inclusive term than perimenopause or menopause,
covering the entire transition.
,2. Anti-Mullerian hormone (AMH) levels:
A) Increase after menopause
B) Remain stable until menopause then drop
C) Decline progressively with age and become undetectable after menopause
D) Fluctuate with the menstrual cycle
Answer: C) Decline progressively with age and become undetectable after
menopause
Rationale: AMH is produced by granulosa cells of small antral follicles and
declines progressively with age, becoming undetectable after menopause. Unlike
FSH, AMH has minimal cycle-to-cycle variability, making it a reliable marker of
ovarian reserve.
3. Which change is NOT part of normal reproductive aging?
A) Increased FSH
B) Increased antral follicle count
C) Decreased inhibin B
D) Increased cycle irregularity
Answer: B) Increased antral follicle count
Rationale: Antral follicle count declines with age, not increases. Increased FSH,
decreased inhibin B, and increased cycle irregularity are all hallmark features of
reproductive aging. A rising antral follicle count would suggest a condition like
PCOS, not normal menopause.
4. The term "perimenopause" encompasses:
A) Only the early menopausal transition
B) The late transition plus first 12 months of amenorrhea
C) The entire reproductive period
D) Only postmenopausal
Answer: B) The late transition plus first 12 months of amenorrhea
Rationale: Perimenopause includes the menopausal transition (early and late) plus
the 12 months following the final menstrual period. It ends after 12 months of
amenorrhea, at which point the woman is considered postmenopausal.
5. What is the definition of "early menopause"?
A) LMP before age 40
B) LMP before age 45
,C) LMP before age 50
D) LMP after age 55
Answer: B) LMP before age 45
Rationale: Early menopause is defined as the last menstrual period (LMP)
occurring before age 45. It should be distinguished from primary ovarian
insufficiency, which occurs before age 40.
6. What is the definition of "late menopause"?
A) LMP after age 50
B) LMP after age 54
C) LMP after age 55
D) LMP after age 60
Answer: B) LMP after age 54
Rationale: Late menopause is defined as an LMP after age 54.
7. What term describes menopause that occurs before age 40?
A) Early menopause
B) Premature ovarian insufficiency (POI)
C) Late menopause
D) Premenopause
Answer: B) Premature ovarian insufficiency (POI)
Rationale: Primary ovarian insufficiency (POI) is defined as the loss of ovarian
function before the age of 40. It is distinguished from early menopause, which
occurs between ages 40 and 45.
8. According to the STRAW+10 staging system, what characterizes "early
menopause transition" (stage -2)?
A) 60 or more consecutive days of amenorrhea
B) Persistent difference of 7 days or more in the length of consecutive cycles
C) Heavy menstrual bleeding
D) Regular cycles 26-35 days
Answer: B) Persistent difference of 7 days or more in the length of consecutive
cycles
Rationale: Stage -2 (early menopause transition) is marked by persistent difference
of ≥7 days in the length of consecutive cycles and is when cycle irregularity
begins.
, 9. What does the luteal out-of-phase (LOOP) event explain?
A) Elevated FSH in early menopause
B) Elevated estrogen levels in perimenopausal women
C) Low progesterone in perimenopause
D) Androgen excess in menopause
Answer: B) Elevated estrogen levels in perimenopausal women
Rationale: The LOOP event explains why some perimenopausal women have
elevated estrogen levels occasionally. Elevated FSH recruits a second follicle,
causing a follicular-phase-like rise in estradiol superimposed on the mid- to late
luteal phase of the ovulatory cycle.
10. The STRAW+10 staging system for reproductive aging divides the female
lifespan into how many principal stages?
A) Three (pre-, peri-, post-)
B) Seven stages (-5 through +2), progressing from Reproductive (-5/-4/-3) to
Menopausal Transition (-2/-1) to Postmenopause (+1/+2), anchored by the final
menstrual period (FMP)
C) Five (only reproductive through late postmenopause, excluding early)
D) Ten (based on decade of life)
Answer: B) Seven stages (-5 through +2), progressing from Reproductive (-5/-4/-3)
to Menopausal Transition (-2/-1) to Postmenopause (+1/+2), anchored by the final
menstrual period (FMP)
Rationale: The STRAW+10 (Stages of Reproductive Aging Workshop +10)
staging system is the international standard for describing reproductive aging
across seven stages, anchored by the final menstrual period (FMP at Stage 0).
Stages -5 through -3 are reproductive, -2 through -1 mark the menopausal
transition (perimenopause), and +1 (early postmenopause) and +2 (late
postmenopause) follow. Criteria include menstrual cycle patterns, endocrine
markers (FSH, AMH, inhibin B, antral follicle count), and symptomatology.
11. According to STRAW+10, the final menstrual period (FMP) is defined as:
A) The final menstrual period after which a woman has experienced 12
consecutive months of amenorrhea with no other pathologic or physiologic cause
B) The last period of a woman's reproductive life confirmed only by FSH >40
mIU/mL on one occasion
C) The first skipped period after age 40
D) Any period occurring after age 45
MENOPAUSE SOCIETY CERTIFICATION PREP
EXAM 300 ACTUAL QUESTIONS AND CORRECT
ANSWERS WITH RATIONALE LATEST UPDATE
ALREADY GRADED A+ ASSURED PASS
The Menopause Society Certified Practitioner (MSCP) Exam 2026 is a
competency assessment for healthcare professionals specializing in midlife
women’s health. Updated for 2026, it covers physiology and pathophysiology of
menopause, symptoms and concerns, health disorders in midlife, treatment options,
and preventive care and counseling. The exam consists of 300 multiple-choice
questions with three response alternatives, testing clinical knowledge and
evidence-based practice. This comprehensive prep resource provides 300 unique
practice questions with detailed rationales, organized into five sections. It helps
candidates identify strengths, reinforce key concepts, and build confidence for
successful certification and improved overall patient care in clinical menopause
management.
SECTION 1: PHYSIOLOGY AND PATHOPHYSIOLOGY
OF THE MENOPAUSE TRANSITION (Questions 1–57)
1. What is the "climacteric phase"?
A) The final menstrual period
B) The period of endocrinologic, somatic, and transitory psychologic changes
around the time of menopause
C) The perimenopause only
D) The postmenopausal period
Answer: B) The period of endocrinologic, somatic, and transitory psychologic
changes around the time of menopause
Rationale: The climacteric phase is the broad period of endocrine, physical, and
psychological changes that occur as a woman transitions from reproductive to non-
reproductive status. It is a more inclusive term than perimenopause or menopause,
covering the entire transition.
,2. Anti-Mullerian hormone (AMH) levels:
A) Increase after menopause
B) Remain stable until menopause then drop
C) Decline progressively with age and become undetectable after menopause
D) Fluctuate with the menstrual cycle
Answer: C) Decline progressively with age and become undetectable after
menopause
Rationale: AMH is produced by granulosa cells of small antral follicles and
declines progressively with age, becoming undetectable after menopause. Unlike
FSH, AMH has minimal cycle-to-cycle variability, making it a reliable marker of
ovarian reserve.
3. Which change is NOT part of normal reproductive aging?
A) Increased FSH
B) Increased antral follicle count
C) Decreased inhibin B
D) Increased cycle irregularity
Answer: B) Increased antral follicle count
Rationale: Antral follicle count declines with age, not increases. Increased FSH,
decreased inhibin B, and increased cycle irregularity are all hallmark features of
reproductive aging. A rising antral follicle count would suggest a condition like
PCOS, not normal menopause.
4. The term "perimenopause" encompasses:
A) Only the early menopausal transition
B) The late transition plus first 12 months of amenorrhea
C) The entire reproductive period
D) Only postmenopausal
Answer: B) The late transition plus first 12 months of amenorrhea
Rationale: Perimenopause includes the menopausal transition (early and late) plus
the 12 months following the final menstrual period. It ends after 12 months of
amenorrhea, at which point the woman is considered postmenopausal.
5. What is the definition of "early menopause"?
A) LMP before age 40
B) LMP before age 45
,C) LMP before age 50
D) LMP after age 55
Answer: B) LMP before age 45
Rationale: Early menopause is defined as the last menstrual period (LMP)
occurring before age 45. It should be distinguished from primary ovarian
insufficiency, which occurs before age 40.
6. What is the definition of "late menopause"?
A) LMP after age 50
B) LMP after age 54
C) LMP after age 55
D) LMP after age 60
Answer: B) LMP after age 54
Rationale: Late menopause is defined as an LMP after age 54.
7. What term describes menopause that occurs before age 40?
A) Early menopause
B) Premature ovarian insufficiency (POI)
C) Late menopause
D) Premenopause
Answer: B) Premature ovarian insufficiency (POI)
Rationale: Primary ovarian insufficiency (POI) is defined as the loss of ovarian
function before the age of 40. It is distinguished from early menopause, which
occurs between ages 40 and 45.
8. According to the STRAW+10 staging system, what characterizes "early
menopause transition" (stage -2)?
A) 60 or more consecutive days of amenorrhea
B) Persistent difference of 7 days or more in the length of consecutive cycles
C) Heavy menstrual bleeding
D) Regular cycles 26-35 days
Answer: B) Persistent difference of 7 days or more in the length of consecutive
cycles
Rationale: Stage -2 (early menopause transition) is marked by persistent difference
of ≥7 days in the length of consecutive cycles and is when cycle irregularity
begins.
, 9. What does the luteal out-of-phase (LOOP) event explain?
A) Elevated FSH in early menopause
B) Elevated estrogen levels in perimenopausal women
C) Low progesterone in perimenopause
D) Androgen excess in menopause
Answer: B) Elevated estrogen levels in perimenopausal women
Rationale: The LOOP event explains why some perimenopausal women have
elevated estrogen levels occasionally. Elevated FSH recruits a second follicle,
causing a follicular-phase-like rise in estradiol superimposed on the mid- to late
luteal phase of the ovulatory cycle.
10. The STRAW+10 staging system for reproductive aging divides the female
lifespan into how many principal stages?
A) Three (pre-, peri-, post-)
B) Seven stages (-5 through +2), progressing from Reproductive (-5/-4/-3) to
Menopausal Transition (-2/-1) to Postmenopause (+1/+2), anchored by the final
menstrual period (FMP)
C) Five (only reproductive through late postmenopause, excluding early)
D) Ten (based on decade of life)
Answer: B) Seven stages (-5 through +2), progressing from Reproductive (-5/-4/-3)
to Menopausal Transition (-2/-1) to Postmenopause (+1/+2), anchored by the final
menstrual period (FMP)
Rationale: The STRAW+10 (Stages of Reproductive Aging Workshop +10)
staging system is the international standard for describing reproductive aging
across seven stages, anchored by the final menstrual period (FMP at Stage 0).
Stages -5 through -3 are reproductive, -2 through -1 mark the menopausal
transition (perimenopause), and +1 (early postmenopause) and +2 (late
postmenopause) follow. Criteria include menstrual cycle patterns, endocrine
markers (FSH, AMH, inhibin B, antral follicle count), and symptomatology.
11. According to STRAW+10, the final menstrual period (FMP) is defined as:
A) The final menstrual period after which a woman has experienced 12
consecutive months of amenorrhea with no other pathologic or physiologic cause
B) The last period of a woman's reproductive life confirmed only by FSH >40
mIU/mL on one occasion
C) The first skipped period after age 40
D) Any period occurring after age 45
